Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma

被引:16
|
作者
Zhu, Lili [1 ]
Shen, Yiyin [1 ]
Sun, Wei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Stomatol, Shanghai, Peoples R China
关键词
PON3; OSCC; Cell proliferation; AP-1; IMMUNE ESCAPE; CANCER; PATHWAY;
D O I
10.1016/j.biopha.2016.11.084
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Paraoxonase 3 (PON3) is an oncogene in cancer, however, little is known about the mechanisms and roles of PON3 in oral squamous cell carcinoma (OSCC), which is the aim of our study. We found that the expression of PON3 was up-regulated in OSCC samples and cell lines. PON3 was associated with accelerating cell proliferation, cell cycle, migration and invasion in OSCC cells. Further research showed that PON3 was regulated by PI3K/Akt pathway. We also found that AP-1 was an important transcriptional factor regulating PON3 expression in OSCC. The study elucidates that PI3K/Akt pathway up-regulated the expression of PON3 in OSCC by AP-1. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:712 / 717
页数:6
相关论文
共 50 条
  • [1] SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K/AKT/PDGFB/PDGFR axis
    Jing, Yue
    Jin, Yue
    Wang, Yujia
    Chen, Sheng
    Zhang, Xiaoxin
    Song, Yuxian
    Wang, Zhiyong
    Pu, Yumei
    Ni, Yanhong
    Hu, Qingang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) : 15581 - 15593
  • [2] The role of PI3K/AKT pathway in cell proliferation and apoptosis in oral Squamous Cell Carcinoma
    Ribeiro-Silva, A.
    Duarte, A.
    Silveira, G.
    VIRCHOWS ARCHIV, 2016, 469 : S116 - S116
  • [3] Increased LGALS3BP promotes proliferation and migration of oral squamous cell carcinoma via PI3K/AKT pathway
    Zhang, Xiaoxin
    Ding, Haoyue
    Lu, Zhanyi
    Ding, Liang
    Song, Yuxian
    Jing, Yue
    Hu, Qingang
    Dong, Yingchun
    Ni, Yanhong
    CELLULAR SIGNALLING, 2019, 63
  • [4] P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K/AKT signaling pathway in oral squamous cell carcinoma
    Chi, Zengpeng
    Wang, Qimin
    Wang, Xin
    Li, Dagang
    Tong, Lei
    Shi, Yu
    Yang, Fang
    Guo, Qingyuan
    Zheng, Jiawei
    Chen, Zhenggang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma
    Wang, H.
    Wu, Q.
    Liu, Z.
    Luo, X.
    Fan, Y.
    Liu, Y.
    Zhang, Y.
    Hua, S.
    Fu, Q.
    Zhao, M.
    Chen, Y.
    Fang, W.
    Lv, X.
    CELL DEATH & DISEASE, 2014, 5 : e1155 - e1155
  • [6] Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma
    H Wang
    Q Wu
    Z Liu
    X Luo
    Y Fan
    Y Liu
    Y Zhang
    S Hua
    Q Fu
    M Zhao
    Y Chen
    W Fang
    X Lv
    Cell Death & Disease, 2014, 5 : e1155 - e1155
  • [7] PAR-2 promotes cell proliferation, migration, and invasion through activating PI3K/AKT signaling pathway in oral squamous cell carcinoma
    Tang, Kai-Liang
    Tang, Han-Ying
    Du, Yi
    Tian, Tian
    Xiong, Shi-Jiang
    BIOSCIENCE REPORTS, 2019, 39
  • [8] Ailanthone Inhibits Cell Proliferation in Tongue Squamous Cell Carcinoma via PI3K/AKT Pathway
    Wang, Shuhan
    Cui, Qixiao
    Chen, Xiaoyu
    Zhu, Xuejie
    Lin, Kehao
    Zheng, Qiusheng
    Wang, Yuliang
    Li, Defang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [9] RETRACTION: PAR-2 promotes cell proliferation, migration and invasion through activating PI3K/AKT signaling pathway in oral squamous cell carcinoma
    Tang, Kai-Liang
    Xiong, Shi-Jiang
    BIOSCIENCE REPORTS, 2024, 44 (07)
  • [10] DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway
    Guo, Wenbo
    Qu, Yun
    Yu, Yang
    Li, Xueming
    Liang, Zhuang
    Wang, Zhaoqi
    Hu, Tenglong
    Zhou, Shan
    AGING-US, 2024, 16 (10): : 9204 - 9215